PPHM : Summary for Peregrine Pharmaceuticals Inc. - Yahoo Finance

U.S. Markets closed

Peregrine Pharmaceuticals, Inc. (PPHM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.31+0.01 (+4.93%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close0.29
Bid0.29 x 10000
Ask0.52 x 6200
Day's Range0.29 - 0.31
52 Week Range0.28 - 1.12
Avg. Volume1,680,390
Market Cap78.74M
PE Ratio (TTM)-1.21
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks14 hours ago

    Peregrine Pharmaceuticals (PPHM) Sees Hammer Chart Pattern: Time to Buy?

    Peregrine Pharmaceuticals, Inc. (PPHM) has been struggling lately, but the selling pressure may be coming to an end soon

  • Capital Cube4 days ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • American City Business Journals7 days ago

    Heat Biologics to reap benefit of new biotech

    Heat Biologics recently announced the appointment of Peregrine Pharmaceuticals (PPHM) alum Dr. Jeff Hutchins as its new chief scientific officer and senior vice president of preclinical development, but the company also stands to benefit from where its former CSO has headed. Former CSO Dr. Taylor Schreiber will not only chair Heat’s scientific advisory board, he’ll also serve as CSO of new biotechnology company Shattuck Labs Inc., according to an announcement from Heat. Shattuck is “developing technology exclusively licensed from Heat,” the Durham-based company said.